FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W186323258> ?p ?o ?g. }

• W186323258 endingPage "101" @default.
• W186323258 startingPage "93" @default.
• W186323258 abstract "The impact of adjuvant chemotherapy (CT) in the management of resectable non-small cell lung cancer (NSCLC) is highly debated. The aim of the study was to evaluate the outcome of this category of patients, treated at the Military Hospital Bucharest (surgery) and Institute of Oncology Bucharest (CT).We retrospectively analyzed the survival data according to various patients' characteristics, the corresponding pattern of relapses, along with the data concerning the CT program.A number of 311 consecutively treated patients (pts.), between January 1994 and October 2002, were evaluated. All patients were radically resected and received adjuvant CT. Chemotherapy was planned to be cisplatin-based and to be delivered for six cycles. In addition, 141 pts. (45%) received post-operative irradiation (RT). demographics: sex, M 252 (81%)/F 59 (19%) and median age: 58 (range 31-75). Stage: I 55 (17%), II 71 (23%), III A 140 (45%) and III B 45 (15%). After a median follow-up of 46 months, the overall median survival (MS), considering all the patients, was 42 months and the 5-year survival rate (5-year SR) was 44%. According to stage, MS and 5-year SR were as follows: Stage I = not reached/94%; Stage II = 54 months/59%; Stage III A = 28 months/37% and Stage III B= 18 months/27%. According to lymph node status, the MS was not reached for pN-negative pts. and 26 months for pN-positive pts. (P = 0.0002), while the 5-year SR was 75% versus 35%, respectively. Platinum-based CT was delivered in 295 pts. (95%). The medium number of cycles was five. A number of 86 (28%) relapses were recorded, of which 50 (16%) were distant, 25 (8%) local and 11 (4%) distant and local. The sites of the 50 distant relapses were BRA 24 (48%), OSS 10 (20%), PUL 6 (12%) and OTH 10 (20%).Our analysis shows good long-term survival data for adjuvant CT following surgery in NSCLC, which looks comparatively superior to those communicated for surgery-only series. Pathologic invasion of the lymph nodes has a strong adverse effect on patients' outcome. The positive impact of CT in this setting is indirectly sustained by the pattern of relapses, which place the brain sanctuary on the first rank. Overall, the patients' compliance was good and we delivered a medium of five cycles of adjuvant platinum-based CT." @default.
• W186323258 created "2016-06-24" @default.
• W186323258 creator A5006583909 @default.
• W186323258 creator A5007546391 @default.
• W186323258 creator A5010705536 @default.
• W186323258 creator A5015325613 @default.
• W186323258 creator A5016586743 @default.
• W186323258 creator A5029692581 @default.
• W186323258 creator A5050917068 @default.
• W186323258 creator A5067088447 @default.
• W186323258 creator A5074451299 @default.
• W186323258 creator A5077459059 @default.
• W186323258 creator A5087195423 @default.
• W186323258 date "2005-01-01" @default.
• W186323258 modified "2023-10-18" @default.
• W186323258 title "Adjuvant chemotherapy for radically resected non-small cell lung cancer" @default.
• W186323258 cites W1571344193 @default.
• W186323258 cites W1884346826 @default.
• W186323258 cites W1902073354 @default.
• W186323258 cites W1907932102 @default.
• W186323258 cites W1967929572 @default.
• W186323258 cites W1968431457 @default.
• W186323258 cites W1971694535 @default.
• W186323258 cites W1975549289 @default.
• W186323258 cites W1991407309 @default.
• W186323258 cites W2005591739 @default.
• W186323258 cites W2014699857 @default.
• W186323258 cites W2027022759 @default.
• W186323258 cites W2055543087 @default.
• W186323258 cites W2070471589 @default.
• W186323258 cites W2073179530 @default.
• W186323258 cites W2085515366 @default.
• W186323258 cites W2087262736 @default.
• W186323258 cites W2117994949 @default.
• W186323258 cites W2135800076 @default.
• W186323258 cites W2228803286 @default.
• W186323258 cites W2315493012 @default.
• W186323258 cites W2400914614 @default.
• W186323258 cites W2424811126 @default.
• W186323258 cites W2504684570 @default.
• W186323258 cites W651944170 @default.
• W186323258 doi "https://doi.org/10.1016/j.lungcan.2004.06.008" @default.
• W186323258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15603859" @default.
• W186323258 hasPublicationYear "2005" @default.
• W186323258 type Work @default.
• W186323258 sameAs 186323258 @default.
• W186323258 citedByCount "4" @default.
• W186323258 countsByYear W1863232582012 @default.
• W186323258 countsByYear W1863232582020 @default.
• W186323258 crossrefType "journal-article" @default.
• W186323258 hasAuthorship W186323258A5006583909 @default.
• W186323258 hasAuthorship W186323258A5007546391 @default.
• W186323258 hasAuthorship W186323258A5010705536 @default.
• W186323258 hasAuthorship W186323258A5015325613 @default.
• W186323258 hasAuthorship W186323258A5016586743 @default.
• W186323258 hasAuthorship W186323258A5029692581 @default.
• W186323258 hasAuthorship W186323258A5050917068 @default.
• W186323258 hasAuthorship W186323258A5067088447 @default.
• W186323258 hasAuthorship W186323258A5074451299 @default.
• W186323258 hasAuthorship W186323258A5077459059 @default.
• W186323258 hasAuthorship W186323258A5087195423 @default.
• W186323258 hasConcept C121608353 @default.
• W186323258 hasConcept C126322002 @default.
• W186323258 hasConcept C141071460 @default.
• W186323258 hasConcept C144024400 @default.
• W186323258 hasConcept C146357865 @default.
• W186323258 hasConcept C149923435 @default.
• W186323258 hasConcept C151730666 @default.
• W186323258 hasConcept C2776256026 @default.
• W186323258 hasConcept C2776694085 @default.
• W186323258 hasConcept C2778239845 @default.
• W186323258 hasConcept C2780084366 @default.
• W186323258 hasConcept C2780849966 @default.
• W186323258 hasConcept C71924100 @default.
• W186323258 hasConcept C86803240 @default.
• W186323258 hasConceptScore W186323258C121608353 @default.
• W186323258 hasConceptScore W186323258C126322002 @default.
• W186323258 hasConceptScore W186323258C141071460 @default.
• W186323258 hasConceptScore W186323258C144024400 @default.
• W186323258 hasConceptScore W186323258C146357865 @default.
• W186323258 hasConceptScore W186323258C149923435 @default.
• W186323258 hasConceptScore W186323258C151730666 @default.
• W186323258 hasConceptScore W186323258C2776256026 @default.
• W186323258 hasConceptScore W186323258C2776694085 @default.
• W186323258 hasConceptScore W186323258C2778239845 @default.
• W186323258 hasConceptScore W186323258C2780084366 @default.
• W186323258 hasConceptScore W186323258C2780849966 @default.
• W186323258 hasConceptScore W186323258C71924100 @default.
• W186323258 hasConceptScore W186323258C86803240 @default.
• W186323258 hasIssue "1" @default.
• W186323258 hasLocation W1863232581 @default.
• W186323258 hasLocation W1863232582 @default.
• W186323258 hasOpenAccess W186323258 @default.
• W186323258 hasPrimaryLocation W1863232581 @default.
• W186323258 hasRelatedWork W167319750 @default.
• W186323258 hasRelatedWork W2058846783 @default.
• W186323258 hasRelatedWork W2263955356 @default.
• W186323258 hasRelatedWork W2367461116 @default.

• next